MIRA INFORM REPORT
|
Report Date : |
19.03.2012 |
IDENTIFICATION DETAILS
|
Name : |
ARYSTA LIFESCIENCE CORPORATION |
|
|
|
|
Registered Office : |
St Luke’s Tower 38/39F, 8-1 Akashicho
Chuoku Tokyo 104-0044 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
April 1977 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Import, Export, Wholesale of agrochemicals, pharmaceutical
intermediates |
|
|
|
|
No. of Employees
: |
100 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
Yen 169.9 Million |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
---- |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Japan |
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
ARYSTA LIFESCIENCE CORPORATION
Arysta LifeScience
KK
St Luke’s Tower
38/39F, 8-1 Akashicho Chuoku Tokyo 104-0044 JAPAN
Tel:
03-3547-4500 Fax: 03-3547-4699
URL http://www.arystalifescience.com
E-Mail address: info@arystalifescience.com
Import,
export, wholesale of agrochemicals,
pharmaceutical intermediates
Sapporo,
Osaka, Fukuoka
Arysta
LifeScience N America, Arysta LifeScience Europe, Africa & Mid East,
Arysta
LifeScience S America, Arysta LifeScience Haesom Corp (Korea),
Bloomers
Growers (New Zealand), Arysta LifeScience Maqyarorszy Kft
(Hungary), Callivoire (Cote D’ivoir)
(--subsidiaries)
WAYNE
HEWETT, PRES Rudorf Van Houten,
rep dir
Christopher
Richards, ch John Coyle, dir
Paul
Mullins, dir Alexander
Emery, dir
Yen
Amount: In million Yen, unless
otherwise stated
FINANCES FAIR A/SALES Yen 12,545 M
PAYMENTS No Complaints CAPITAL Yen
59,399 M
TREND SLOW WORTH Yen
53,282 M
STARTED 1977 EMPLOYES 100
TRADING HOUSE SPECIALIZING IN AGROCHEMICALS &
PHARMACEU-TICAL INTERMEDIATES, OWNED BY IEIL JAPAN.
FINANCIAL SITUATION CONSIDERED
FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS
MAX
CREDIT LIMIT: YEN 169.9 MILLION, 30 DAYS NORMAL TERMS. .
The subject company was established jointly by Tomen Corp (now Toyota Tsusho Corp) and Nichimen Corp (now Sojitz Corp) in order to advance into new area of life science: agrochemicals and pharmaceutical chemicals. This is a trading house for import, export and wholesale of agrochemicals & pharmaceutical intermediates. Handles a wide range of brands (See OPERATION). Active in overseas expansion. The ownership of the firm changed to IEIL Japan Co, a capital fund investor owned by IEIL Ireland (Permira Funds), in Jun/2008. Domestic clients include major pharmaceuticals & chemicals mfrs, nationwide.
The sales volume for Dec/2011 fiscal term amounted to Yen 12,545 million, a 31% down from Yen 18,182 million in the previous term. The operations continued in the red to register Yen 20,400 million recurring loss and Yen 9,525 million net losses, respectively, compared with Yen 13,204 million recurring loss and Yen 11,154 million net losses, respectively, a year ago.
For the current term ending Dec 2012 the operations are projected to come back to profitability but still limited to a minimum amount post-taxes, on a 2% rise in turnover, to Yen 12,800 million. .
The financial situation is considered FAIR and good for ORDINARY business engagements. Max credit limit is estimated at Yen 169.9 million, on 30 days normal terms.
Date Registered: Apr 1977
Legal Status:
Limited Company (Kabushiki Kaisha)
Authorized:
1,187,986 shares
Issued:
1,187,986 shares
Sum: Yen 59,399 million
Major shareholders (%): IEIL Japan Co Ltd* (Industrial
Equity Investment Ltd) (100)
* Investment fund company &
management, owned by IEIL Ireland (Industrial Equity Investment Ltd), acquired
the firm in Jun/2008.
Nothing
detrimental is known as to the commercial morality of executives.
Activities: A trading house for import, export and wholesale of agrochemicals, pharma-ceuticals intermediates & materials, cosmetics raw materials, health foods, organic chemical intermediates, veterinary products including veterinary medicines & fee additives, others (--100%).
(Handling Brands)
Select (Registered), Captain, Everest (Registered), Orthene (Registered), Elevate Registered), Clutch, Eminent, Monitor, CaptEvate, Maestro, other.
Clients: [Pharmaceutical mfrs, chemical firms, wholesalers] Takeda Chemical Ind,
Toyota Tsusho Corp, Sojitz Corp, Sumitomo Chemical, Toyo Green Inc, Hokko Chemical
Ind, Yonezawa Chemical Co, other.
No. of accounts: 1,000
Domestic areas of activities: Nationwide
Suppliers: [Mfrs, wholesalers] Takeda Chemical Ind, Nissan Chemical Ind, Kumiai Chemical Ind, Nippon Soda Co, Yonezawa Chemical Co, other.
Payment record: No Complaints
Location: Business area in Tokyo. Office premises at the caption address are leased and maintained satisfactorily.
Bank References:
Aozora Bank (H/O)
MUFG
(Marunouchi)
Relations:
Satisfactory
(In Million Yen)
|
Terms Ending: |
31/12/2012 |
31/12/2011 |
31/12/2010 |
31/12/2009 |
|
|
Annual
Sales |
|
12,800 |
12,545 |
18,182 |
15,913 |
|
Recur.
Profit |
|
0 |
-20,400 |
-13,204 |
-20,836 |
|
Net
Profit |
|
0 |
-9,525 |
-11,154 |
-39,439 |
|
Total
Assets |
|
|
234,220 |
240,679 |
161,505 |
|
Current
Assets |
|
|
9,378 |
9,762 |
11,213 |
|
Current
Liabs |
|
|
25,493 |
17,935 |
15,784 |
|
Net
Worth |
|
|
53,282 |
62,829 |
73,915 |
|
Capital,
Paid-Up |
|
|
59,399 |
59,399 |
59,399 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
2.03 |
-31.00 |
14.26 |
-47.83 |
|
|
Current Ratio |
|
.. |
36.79 |
54.43 |
71.04 |
|
N.Worth Ratio |
.. |
22.75 |
26.10 |
45.77 |
|
|
R.Profit/Sales |
|
0.00 |
-162.61 |
-72.62 |
-130.94 |
|
N.Profit/Sales |
0.00 |
-75.93 |
-61.35 |
-247.84 |
|
|
Return On Equity |
.. |
-17.87 |
-17.75 |
-53.36 |
|
Note: Forecast (or estimated) for the 31/12/2012 fiscal
term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.50.31 |
|
UK Pound |
1 |
Rs.79.04 |
|
Euro |
1 |
Rs.65.82 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.